Compare HP Inc (HPQ) vs Pfizer Inc (PFE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HP Inc vs Pfizer Inc — how do they compare? HP Inc trades at $30.54 (market cap $29.25B), while Pfizer Inc trades at $28.06 (market cap $158.56B). The key difference: Pfizer Inc is far larger — about 5.4× HP Inc's market cap, and Pfizer Inc pays the higher dividend (6.18%). Which is the better fit depends on your goals — on Pluang, investors hold HP Inc for 70 Days and Pfizer Inc for 158 Days on average.
| HPQ | PFE | |
|---|---|---|
Market Cap | $29.25B | $158.56B |
Volume | 10,025,806 | 44,138,282 |
Sector | Technology | Health |
52-Week High | $35.48 | $29.02 |
52-Week Low | $18.20 | $23.67 |
Typical Hold Time | 70 Days | 158 Days |
Enterprise Value | $35.42B | $210.06B |
Dividend Yield | 3.7% | 6.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HPQ trades at $32.24, up 1.61% with a bullish technical signal from moving averages. The company has beaten earnings estimates for three consecutive quarters, maintaining stable revenue around $55B with a 4.14% net margin. Recent news highlights HP's new PC launches and AI capabilities, though the stock faces headwinds from a projected mid-single-digit PC market decline in 2027.
The outlook is mixed: valuation appears reasonable with a P/E of 12.38 and P/S of 0.51, and strong cash flow supports dividends. However, negative shareholder equity and competitive pressures in the PC market present risks. Analyst consensus is cautious with a $25.75 price target below current levels, suggesting limited near-term upside.
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HP Inc
HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →
